2015-08-11T16:19:09-07:00 2014-12-31 990 2014-01-01 236434390 THE WISTAR INSTITUTE OF ANATOMY & BIOLOGY WIST 2158989910 3601 Spruce Street Philadelphia PA 191044265 Joseph G Trainor Chief Financial Officer 2154956922 2015-08-11 2014 2016-04-25 22:37:26Z Joseph G Trainor 3601 Spruce Street Philadelphia PA 191454265 147682000 0 X www.wistar.org X 1892 PA Biomedical research with special expertise in cancer research and vaccine development 33 33 359 50 42000 -3000 39506000 39654000 2320000 3108000 7784000 7964000 16353000 18232000 65963000 68958000 0 0 0 0 29371000 27573000 0 0 683000 28222000 30335000 57593000 57908000 8370000 11050000 246413000 241477000 86398000 80752000 160015000 160725000 The mission of the Wistar Institute is to marshal the talents of outstanding scientists through a highly enabled culture of biomedical collaboration and innovation in order to solve some of the world's most challenging and important problems in the field of cancer and immunology, and produce ground-breaking advances in world health. Consistent with a pioneering legacy of leadership in not-for-profit biomedical research and a track-record of life-saving contributions in immunology and cell biology, The Wistar Institute aims to pursue novel and courageous research paths to life science discovery, and to accelerate/potentiate the impact of those discoveries by shortening the path from bench to bedside. 0 0 45265000 0 3108000 CANCER CENTER - The Wistar Institute Cancer Center has a history of significant advances in cancer genetics, cancer biology, tumor immunology, and virology. The Cancer Center merges the study of cancer biology with translational advances toward cancer prevention, diagnosis, and therapy. Cancer Center scientists conduct research on the entire spectrum of cancer biology. Their pioneering work spans from genetics and the molecular and cellular events that spawn cancer, to the role of the tumor microenvironment in cancer metastasis. Their research also targets how the human immune system can be trained to recognize and fight tumors, with the potential to drive immune system therapies. Accomplishments of the Cancer Center; Identifying the genes associated with breast, lung, and prostate cancers; Pioneering the science of monoclonal antibodies used to study the pathways and proteins involved in tumor development; Improving cancer treatments and diagnostic tests for disease, including a recent blood test for lung cancer, currently in clinical trials. MELANOMA RESEARCH CENTER - The Wistar Institute Melanoma Research Center brings together a core group of cancer researchers to leverage their melanoma expertise into partnerships with medical, pharmaceutical, government, and advocacy groups. The group studies the unique biology of melanoma with the goal of developing new therapies, diagnostic tests and preventive measures to curb the rising death rates from melanoma. VACCINE CENTER - The Vaccine Center leverages the Institute's strengths in immunology, virology, and other research disciplines to create and improve vaccines to enhance public health in the United States and around the globe. The Wistar Institute's proven record of success in vaccine development includes the creation of the standard-of-care protections against rubella, rabies, and rotavirus. The Wistar Institute Vaccine Center is now in development of a vaccine for HIV, which is currently on track to begin a clinical trial with the National Institutes of Health; influenza (a "universal" flu vaccine that will forgo the need for annual shots); malaria; and tuberculosis. The Center is also developing the first therapeutic vaccine against cervical cancer and other cancers caused by human papillomavirus (HPV). TRAINING AND OUTREACH - Education and training are central to The Wistar Institute's mission. In the past decade alone, nearly 1,000 promising researchers were trained at Wistar, including pre-doctoral students, postdoctoral fellows, and visiting scientists. Providing science and cancer education to high school students and underserved populations in the community is a priority. Wistar's Biomedical Technician Training Program prepares students for new career opportunities as research technicians. This program is a joint effort between Wistar and the Community College of Philadelphia, which combines academic course work with specialized hands-on training in research laboratories at Wistar and other affiliated research institutes. 0 0 0 Not applicable 0 0 0 Not applicable 0 0 0 45265000 1 1 0 1 0 0 0 1 0 1 1 1 0 0 1 1 1 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 0 0 1 113 0 1 359 1 1 1 0 0 0 0 1 1 0 0 0 0 X 33 33 1 0 0 0 0 1 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AK AL AZ CA CO CT FL GA HI IL KS KY LA MA MD ME MI MN MO MS NC ND NH NJ NM NY OH OK OR PA RI SC TN UT VA WA WI WV X Joseph G Trainor CFO 2154956922 3601 Spruce Street Philadelphia PA 191044265 Helen P Pudlin Chair 4.00 0.00 X X 0 0 0 Richard Horowitz Vice Chair 4.00 0.00 X X 0 0 0 Maida Milone Secretary 2.00 0.00 X X 0 0 0 Elizabeth McKee Anderson Trustee 1.00 0.00 X 0 0 0 Van Billet Trustee 0.25 0.00 X 0 0 0 Robert S Blank Trustee 1.00 0.00 X 0 0 0 Douglas D Briggs Trustee 1.00 0.00 X 0 0 0 Ira Brind Trustee 1.00 0.00 X 0 0 0 Ronald Caplan Trustee 2.00 0.00 X 0 0 0 Brian H Dovey Trustee 1.00 0.00 X 0 0 0 Daniel Fitzpatrick Trustee 0.25 0.00 X 0 0 0 Robert A Fox Trustee 2.00 0.00 X 0 0 0 L Patrick Gage PhD Trustee 1.00 0.00 X 0 0 0 Joseph A Goldblum Trustee 1.00 0.00 X 0 0 0 Mark L Greenberg PhD Trustee 1.00 0.00 X 0 0 0 Herbert Kean MD Trustee 0.25 0.00 X 0 0 0 Perry A Lerner Trustee 1.00 0.00 X 0 0 0 Susan S McDonald Trustee 2.00 0.00 X 0 0 0 Abraham L Morris Trustee 1.00 0.00 X 0 0 0 Albert Ominsky Esq Trustee 0.25 0.00 X 0 0 0 Arthur M Pappas Trustee 1.00 0.00 X 0 0 0 Vincent Price PhD Trustee 0.25 0.00 X 0 0 0 Samuel V Rhoads Trustee 1.00 0.00 X 0 0 0 Robert H Rock Trustee 1.00 0.00 X 0 0 0 Gerald B Rorer Trustee 1.00 0.00 X 0 0 0 Adele K Schaeffer Trustee 1.00 0.00 X 0 0 0 Paul J Schmitt Trustee 1.00 0.00 X 0 0 0 Milton S Schneider Trustee 1.00 0.00 X 0 0 0 William A Slaughter Esq Trustee 1.00 0.00 X 0 0 0 Judith Soltz Esq Trustee 1.00 0.00 X 0 0 0 David V Wachs Trustee 0.25 0.00 X 0 0 0 Daniel H Wheeler Esq Trustee 1.00 0.00 X 0 0 0 Edward Ziff PhD Trustee 1.00 0.00 X 0 0 0 Russel Kaufman MD President and CEO 65.00 0.00 X 693000 0 55000 Alan Stiles Chief Operating Officer and Treasurer 55.00 0.00 X 255000 0 57000 Dario Altieri MD Vice President and Cancer Center Director 55.00 0.00 X 385000 0 37000 Elizabeth O'Brien Vice President 55.00 0.00 X 240000 0 56000 George Hobbs Vice President 40.00 0.00 X 56000 0 15000 Eden A Graber Vice President for Development and Marketing 55.00 0.00 X 244000 0 53000 Joseph G Trainor Chief Financial Officer 55.00 0.00 X 231000 0 53000 James Verzella Construction Project Executive 40.00 0.00 X 163000 0 28000 Dmitry I Gabrilovich PhD Professor 55.00 0.00 X 258000 0 62000 Meenhard Herlyn DVM DsC Professor 55.00 0.00 X 238000 0 55000 David Speicher PhD Professor 55.00 0.00 X 231000 0 33000 Hildegund Ertl MD Professor 55.00 0.00 X 226000 0 35000 Frank Rauscher PhD Professor 55.00 0.00 X 236000 0 29000 3456000 0 568000 44 0 1 0 L F Driscoll Co LLC 9 Presidential Blvd P O Box 468 Bala Cynwyd PA 19004 Construction Management 19331000 Architectural Woodwork Industries 1845 Walnut Street 23 Floor Suite 2300 Philadelphia PA 191034799 Construction Management 667000 AlliedBarton Security Services 161 Washington Street Suite 600 Conshohocken PA 19428 Security services 427000 ABM Mid-Atlantic Inc 420 Feheley Drive King of Prussia PA 19406 Janitorial 404000 Flatiron Building Company 5189-91 Ridge Avenue Philadelphia PA 19128 Construction Management 305000 18 0 0 697000 0 31002000 7955000 861000 39654000 Research Contract Revenue 541700 3108000 3108000 0 0 0 0 0 0 3108000 1845000 0 0 1845000 0 0 0 0 18209000 0 0 18209000 51000 0 0 0 51000 0 51000 0 0 51000 84486000 124000 78491000 0 5995000 124000 6119000 0 0 6119000 140000 697000 233000 -93000 0 -93000 Sale of Specialized Services 541700 42000 0 42000 0 Miscellaneous income 900099 23000 0 0 23000 0 0 0 0 65000 68958000 3108000 42000 26154000 2621000 351000 2181000 89000 0 0 0 0 18476000 13176000 5113000 187000 1841000 1198000 624000 19000 3455000 2376000 1037000 42000 1180000 768000 400000 12000 0 0 0 0 424000 0 424000 0 56000 0 56000 0 91000 0 91000 0 0 0 376000 0 376000 0 2022000 870000 1105000 47000 66000 0 52000 14000 479000 64000 396000 19000 310000 189000 120000 1000 0 0 0 0 4751000 841000 3910000 0 439000 237000 191000 11000 0 0 0 0 6000 1000 5000 0 898000 808000 81000 9000 0 0 0 0 5550000 5219000 297000 34000 270000 0 270000 0 Subawards 8153000 8153000 0 0 Lab supplies and equipment agreements 5343000 4235000 1082000 26000 Allocation of Operations & Maintenance expenses 0 6101000 -6178000 77000 1101000 678000 327000 96000 57908000 45265000 11960000 683000 2773000 1454000 12246000 2001000 13540000 10217000 11244000 16132000 0 0 0 0 0 0 43000 35000 806000 872000 166845000 50779000 100979000 116066000 66822000 60425000 37795000 34105000 0 0 0 0 165000 170000 246413000 241477000 14975000 10683000 0 0 2380000 1397000 53027000 54428000 0 0 0 0 13192000 6251000 0 0 2824000 7993000 86398000 80752000 X 103960000 120996000 28096000 9998000 27959000 29731000 160015000 160725000 246413000 241477000 X 11050000 -5063000 0 0 0 -5277000 X 0 1 X 1 1 1 X 49900000 68019000 47565000 39506000 39654000 244644000 49900000 68019000 47565000 39506000 39654000 244644000 244644000 14623000 20332000 16849000 18284000 20105000 90193000 0 0 0 0 0 0 51000 20000 0 5000 23000 99000 334936000 0.73042 0.75220 X Schedule A, Part II, Line 10 Miscellaneous income. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 0 0 0 1 91000 0 0 91000 0 Schedule C, Part II-B, Line 1 The Wistar Institute engaged the services of several lobbying firms whose responsibilities are to provide government relations services to The Wistar Institute at the federal and state level with regard to both regulatory and legislative issues. Duties include monitoring and tracking legislation which may be of interest to The Wistar Institute and assisting in finding funding sources for programs. In addition, a number of Wistar Staff participate in government affairs advocacy on a fairly regular basis (e.g. visits to Congressional offices to advocate for increases in the NIH budget). We also occasionally ask our board, employees or friends/volunteers to write letters or call their representatives regarding legislation that may impact Wistar. 0 0 X X X 0 17076000 1585000 347000 0 656000 0 18352000 13462000 1537000 2563000 0 486000 0 17076000 12084000 247000 1555000 0 424000 0 13462000 12652000 50000 -214000 0 404000 0 12084000 11357000 73000 1502000 0 280000 0 12652000 0.1426 0.674 0.1834 0 0 0 685000 685000 0 90189000 24355000 65834000 0 0 0 0 0 75971000 26424000 49547000 0 0 0 0 116066000 Beneficial interest in perpetual trusts 17194000 F Alternative investments 16911000 F 34105000 Accrued pension expense 6262000 Interest rate swap 1731000 7993000 X 63960000 -5063000 0 0 -126000 -5189000 69149000 0 -191000 -191000 68958000 63250000 0 0 0 5718000 5718000 57532000 0 376000 376000 57908000 Schedule D, Part III, Line 1 Collections consist of Family Memorabilia and other artifacts which is not used in the Institute's operations. Schedule D, Part III, Line 4 The Institute's collections constitute a history of medical science in Philadelphia and the history of vaccine development. The museum collections are tied to our deeds of trust and have significant historical value as Wistar was established as the first independent nonprofit biomedical research institute in the country. Schedule D, Part V, Line 4 Management determines the prudent use for the endowment funds for general purposes and to support research and training programs as specified by the various endowment programs. Schedule D, Part X, Line 2 The Institute is a not-for-profit institution which has been determined by the Internal Revenue Service to be exempt from federal income taxes under Section 501(c)(3) of the Internal Revenue Code (IRC). The Institute accounts for uncertainties in income taxes in accordance with authoritative guidance, which prescribes a recognition threshold of more-likely-than-not to be sustained upon examination by the appropriate taxing authority. Measurement of the tax uncertainty occurs if the recognition threshold has been met. Management believes that there were no tax uncertainties that met the recognition threshold for the years ended December 31, 2014 and 2013. Schedule D, Part XI, Line 2d Gain on beneficial interests in trusts $221,000; change in cash surrender value of life insurance policies $29,000; and investment management and advisory fees <$376,000>. Schedule D, Part XI, Line 4b Fundraising event expenses ($233,000); and sale of specialized services $42,000. Schedule D, Part XII, Line 2d Pension-net loss ($4,337,000); Interest rate swap - net loss ($1,190,000); fundraising event expenses ($233,000); and sale of specialized services $42,000 Schedule D, Part XII, Line 4b Investment management and advisory fees Taxin Golf Tournament 196000 173000 23000 0 7000 9000 19000 0 12000 Wistar Gala 641000 524000 117000 0 2000 18000 97000 17000 52000 0 837000 697000 140000 0 9000 27000 116000 17000 64000 233000 -93000 X X X X 0 1 X X X X 0 0 0 0 0 0 0 1 0 Russel Kaufman MD President and CEO 543000 0 100000 0 50000 0 34000 0 21000 0 748000 0 0 0 Dario Altieri MD Vice President and Cancer Center Director 378000 0 5000 0 2000 0 34000 0 3000 0 422000 0 0 0 Alan Stiles Chief Operating Officer and Treasurer 232000 0 10000 0 13000 0 33000 0 24000 0 312000 0 0 0 Eden A Graber Vice President for Development and Marketing 148000 0 7000 0 89000 0 32000 0 21000 0 297000 0 0 0 Elizabeth O'Brien Vice President 215000 0 10000 0 15000 0 31000 0 25000 0 296000 0 0 0 Joseph G Trainor Chief Financial Officer 192000 0 5000 0 34000 0 27000 0 26000 0 284000 0 0 0 James Verzella Construction Project Executive 113000 0 50000 0 0 0 22000 0 6000 0 191000 0 0 0 Dmitry I Gabrilovich PhD Professor 257000 0 0 0 1000 0 34000 0 28000 0 320000 0 0 0 Meenhard Herlyn DVM DsC Professor 233000 0 0 0 5000 0 32000 0 23000 0 293000 0 0 0 David Speicher PhD Professor 229000 0 0 0 2000 0 30000 0 3000 0 264000 0 0 0 Hildegund Ertl MD Professor 225000 0 0 0 1000 0 30000 0 6000 0 262000 0 0 0 Frank Rauscher PhD Professor 221000 0 0 0 15000 0 28000 0 2000 0 266000 0 0 0 Schedule J, Part I, Line 1a Tax Indemnification and gross-up payments - for tuition benefits; Discretionary spending account - travel and auto allowance for CEO only; Housing allowance for CEO only; Social club dues for CEO only. All amounts included in taxable compensation. Schedule J, Part I, Line 1b Tax Indemnification and gross-up payments - yes written policy provided; Discretionary spending account, housing allowance, and social club dues are provided via employment contract with CEO. Schedule J, Part I, Line 7 Non-fixed payments in the form of bonuses approved by the board compensation committee. A Philadelphia Authority for Industrial Development 232237287 2011-07-29 55000000 Capital project financing 0 0 0 A 572000 0 54428000 0 919000 0 519000 0 0 53562000 0 0 2014 0 0 1 1 A 0 0 0 0 0 0 0 0 0 1 A 0 0 1 0 1 1 Citizens Bank of Pennsylvania 10 0 0 0 0 1 A 1 X 22 861000 NYSE 0 0 1 1 Schedule M, Part I, Line 9 The number reported in column (b) line 9 is the number of contributions. Schedule M, Part I, Line 32b Brokerage Services are used to facilitate the process of selling non-cash (stock) contributions. Form 990, Part VI, Section A, Line 2 Daniel Wheeler (Trustee) and Robert Fox (Trustee) have a family relationship. Robert Fox (Trustee) and Richard Horowitz (Trustee) have a business relationship. Form 990, Part VI, Section A, Line 7a The Academy of Natural Sciences at Drexel University and the Wistar Family have the right to designate representation to the Board of Trustees. The University of Pennsylvania approves appointments to the Board of Trustees under the Institute's founding deeds of trust. Form 990, Part VI, Section B, Line 11b The Audit Committee of the Board of Trustees reviews the 990 prior to filing the return. Also, prior to submission, the Institute posts a copy to the Board's website and notifies members of its availability for their information. Form 990, Part VI, Section B, Line 12c Annually covered persons are required to submit Conflict of Interest Disclosures which are reviewed by management. Covered persons include The Wistar Institute's trustees, officers, "key employees", and the next 5 highly compensated employees. If an individual has any power or influence to approve or disapprove a contract or transaction proposed to be entered into between the Institute and any entity or person having a significant relationship to that individual, that individual has a potential conflict of interest and may not participate in the process leading to the approval or disapproval of the contract or transaction unless the underlying facts giving rise to the potential conflict of interest are disclosed and approval for participation is obtained. In the case of the Board of Trustees, no individual with a potential conflict of interest with respect to a contract or transaction or any other conflict of interest may vote to approve or disapprove the contract or transaction. Form 990, Part VI, Section B, Line 15 The Board of Trustees has delegated authority to oversee the compensation paid to the organization's executives to the Executive Evaluation and Compensation Committee made up exclusively of independent members of the Board of Trustees. The committee follows the procedures set forth in the IRS regulations under Section 4958 in making compensation decisions. In particular, the committee annually conducts a review of executive compensation based on independent compensation survey information. At least every other year, the committee engages an independent consultant to collect comparative compensation data and provide a written opinion on the reasonableness of the proposed compensation for executives. In 2014, the committee based its review and approval of proposed compensation on independent data and a reasonableness opinion provided by an independent compensation expert during the previous year, and as well as employee performance assessments and market trend information. The committee documented its compensation decision in contemporaneous written minutes. Form 990, Part VI, Section C, Line 19 The Institute's governing documents and conflict of interest policy are available on the Institute's website (www.wistar.org) The Institute's financial statements are available upon request. Form 990, Part XI, Line 9 Gain on beneficial interests in trusts $221,000; Change in cash surrender value of life insurance policies $29,000; Pension-net loss ($4,337,000); and interest rate swap - net loss ($1,190,000). Issac J Wistar Foundation 3601 Spruce Street Philadelphia PA 19104 232593436 Inactive PA 501 (c) (3) PF N/A 0 Tall Cell Technology L P c/o The Connelly Fdn One Tower Bridge Suite 1450 West Conshohocken PA 19428 232811246 Licensing PA The Wistar Institute of Anatomy and Biology Related 150000 1000 0 7 1 0.9 Beneficial interest in charitable remainder trust PNC Wealth Management 620 Liberty Avenue Pittsburgh PA 15222 Trust PA N/A T 0 170000 1 0 Beneficial interest in perpetual trusts BNY Mellon Wealth Management 1735 Market Street Philadelphia PA 19103 Trusts PA N/A T 822000 15365000 1 0 Beneficial interest in perpetual trusts PNC Institutional Investments 620 Liberty Avenue Pittsburgh PA 15222 Trusts PA N/A T 81000 1829000 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Tall Cell Technology L P a-iii 150000 Cash payment received representing The Wistar Institute's portion in the partnership's royalties.